On September 10, 2020 BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, reported that the Company will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 at 11:45 a.m. ET (Press release, BeiGene, SEP 10, 2020, View Source/news-releases/news-release-details/beigene-present-morgan-stanley-18th-annual-global-healthcare" target="_blank" title="View Source/news-releases/news-release-details/beigene-present-morgan-stanley-18th-annual-global-healthcare" rel="nofollow">View Source [SID1234564965]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast can be accessed from the investors section of BeiGene’s website at View Source or View Source An archived replay will be available following the event for 90 days.